Concepedia

Laurent Knerr

LK

30

Publications

1.1K

Citations

19

H-Index

1996

Active since

Affiliations

AstraZeneca (Sweden)(Current)

UCB Pharma (Belgium)

University of Konstanz

Centre National de la Recherche Scientifique

University of Münster

Laurent Knerr is an author at AstraZeneca (Sweden) specializing in biomolecular engineering, biochemistry, and engineering.

ORCID

Top concepts

Publications per year

1996–2024

30

Publications

30

Targeted delivery of antisense oligonucleotides to pancreatic β-cells

Carina Ämmälä, William J. Drury, Laurent Knerr et al. · Science Advances · 2018 · 177 citations · Full text

<i>O</i>-Glycosyl Trichloroacetimidates Bearing Fmoc as Temporary Hydroxy Protecting Group:  A New Access to Solid-Phase Oligosaccharide Synthesis

Fabien Roussel, Laurent Knerr, Matthias Grathwohl et al. · Organic Letters · 2000 · 77 citations

Late‐Stage Functionalization of Histidine in Unprotected Peptides

Anaïs F. M. Noisier, Magnus J. Johansson, Laurent Knerr et al. · Angewandte Chemie International Edition · 2019 · 74 citations

Design of a small molecule that stimulates vascular endothelial growth factor A enabled by screening RNA fold–small molecule interactions

Hafeez S. Haniff, Laurent Knerr, Xiaohui Liu et al. · Nature Chemistry · 2020 · 72 citations · Full text

, , +8

Glucagon Like Peptide 1 Receptor Agonists for Targeted Delivery of Antisense Oligonucleotides to Pancreatic Beta Cell

Laurent Knerr, Thazha P. Prakash, Richard Lee et al. · Journal of the American Chemical Society · 2021 · 63 citations

Rows per page

1–5 of 30